Participated · Seed · Apr 2026

Copperhelm builds an agentic cloud security platform that uses a Context Lake to structure and connect cloud data and purpose-built AI agents to continuously monitor, investigate, and remediate risks across cloud environments. Its agents perform functions such as network analysis, system behavior inspection, adversary simulation, and automated remediation, and they can connect to live workloads to deploy targeted protections. The company reports it is already running with paying customers, including Fortune 500 enterprises, and cites a customer case where 6 million raw findings were reduced to a few hundred validated risks. Founded by cloud and security veterans Shimon Tolts, Eyar Zilberman, and Roman Labunsky, Copperhelm emphasizes deep cloud architectural expertise. The company plans to use its newly raised $7 million seed capital to accelerate product development, expand go-to-market activities, and grow its engineering team. Copperhelm is headquartered in Tel Aviv.

Participated · Equity · May 2025

Sequence offers an autopilot platform that enables consumers and SMEs to automate the management of finances. The product supports debt repayment strategies, tax automation to set aside funds, debit cards, expense management, virtual bank accounts and real-time cash flow. Banking services for the platform are provided by Thread Bank, Member FDIC. The company said it will use the funds to expand operations, broaden business reach and advance development efforts. The May 2025 raise brought Sequence's total funding to $14.5M. Sequence was founded in June 2023 and is Israeli-founded but based in New York City. Sequence is a Tel Aviv, Israel–based startup that provides a financial router enabling users to visualize their cash flow, establish smart routing rules, and control distribution across multiple accounts. The product integrates banks, apps, loans, credit cards, investment accounts and other financial services into a unified platform. Users leverage the platform to automate financial activities, with reported benefits including debt reduction, long-term investment planning, interest optimization, and building financial safety nets. The company emerged from stealth and is led by co-founder and CEO Gilad Uziely. Sequence intends to use fresh capital to expand operations and broaden its business reach. The article does not disclose operating metrics such as revenue or user counts.

Participated · Equity · Feb 2025

Voyantis applies AI to thousands of data points to predict a customer’s future propensity and lifetime value, and feeds those predictions as signals into ad networks and marketing automation platforms. The platform generates recommendations and targeted actions (for example, when to offer an upsell) and stores only anonymous usage data to protect privacy. Voyantis serves commercial enterprises across industries including fintech, mobile apps, direct-to-consumer, and product-led growth, and counts MoneyLion as a customer. The company competes with firms such as DataScience, Pecan, Ocurate, and Black Crow AI. Voyantis says it has tripled its annual recurring revenue for two consecutive years, signaling strong growth momentum. The startup plans to use new funding for product R&D and to expand its roughly 70-person Tel Aviv-based team. Voyantis offers an AI-driven marketing optimization platform that analyzes a company’s internal business data to surface customer buying preferences and prediction-based insights for ad campaigns. The platform provides integrations with popular advertising and marketing automation tools so businesses can act on predictions and incorporate insights into campaigns. Voyantis says customers have realized an average 47% increase in return on advertising spend using its platform. The product targets retailers and other companies scaling online customer acquisition and retention by identifying high-value and high-retention customers. The startup also positions itself to ease enterprise data science teams' workloads by automating complex data analysis and prediction tasks. Voyantis launched from stealth with $19 million in funding and is promoting adoption through predictive-driven campaign automation and platform integrations.

Participated · Series A · Nov 2024

Medeloop is an AI-driven medical research platform based in Menlo Park, California. Led by CEO Rene Caissie, it automates the entire research cycle—from grant discovery to data analysis—by transforming medical data into a graph database to deliver deep insights and fast results. Its suite includes a grant platform for identifying and applying for funding, a dual-component studies platform (mobile app for participants and web app for researchers), a no-code analytics platform, and a manuscript publication platform. These integrated tools are designed to let researchers manage every aspect of a study from inception to publication. Medeloop partners with healthcare institutions worldwide. The company intends to use the new funds to expand operations and accelerate development efforts. Medeloop offers an AI-driven platform that integrates, harmonizes, and analyzes health data using advanced AI tools to support clinical research. The product streamlines researcher discovery and simplifies grant applications, data collection and harmonization, biomarker and trend identification, and manuscript submissions. Medeloop says these insights have the potential to expedite the clinical research process. The company plans to use the funds to launch an end-to-end solution for early-stage clinical research. Leadership includes CEO Dr. Rene Caissie, CTO Raghav Samavedem, CSO Dr. Josh Walonoski, and COO Andy Yakulis. Medeloop is based in Palo Alto, CA.

Participated · Series F · Oct 2024

Maven Clinic operates a digital, human-led platform that covers the full reproductive life cycle, from preconception and family building to pregnancy, parenting, menopause and midlife. Its platform includes Maven Managed Benefit for fertility benefits, virtual care delivery across maternity, parenting and pediatrics, and menopause programs. More than 2,000 clients in 175 countries use Maven, including Amazon, Microsoft, AT&T, Morgan Stanley and L'Oreal; Parenting & Pediatrics now covers over 3 million lives and Maven's fertility network includes 475+ clinics. Maven says it is the largest fertility benefits provider globally by lives under management; its Maternity & Newborn Care program grew client count more than 400% in the past year, and Menopause & Midlife grew 300% year‑over‑year with 550+ clients offering the program. Maven has published peer‑reviewed studies on clinical and financial outcomes and reports outcomes including reduced C‑section and NICU admission rates. The company has raised more than $425 million to date and plans to invest in its fertility benefits platform, AI personalization, value‑based offerings, and expansion across commercial, fully‑insured and Medicaid lines. Maven Clinic operates a digital virtual clinic for women’s and family health, offering 24/7 virtual care, financial reimbursement support, peer communities, and concierge services. Its platform supports fertility and family building through maternity, parenting, pediatrics and menopause and is used by employers and health plans to reduce costs and improve maternal health outcomes. Maven reports members across 175 countries and emphasizes DE&I in benefits programs. The company plans to use new funding to invest in personalization to drive outcomes in commercial and Medicaid populations, enhance localization to meet cultural and country-specific needs for global members, and increase depth of support across all family and reproductive health life stages. Founded in 2014 by CEO Kate Ryder, Maven has raised a total of $300M to date and recently appointed three independent board members with healthcare and technology experience. Maven Clinic provides a virtual clinic platform for women’s and family health, combining a specialized telehealth network of more than 30 provider types with individual care navigation and Care Advocates. Its offerings span fertility, pregnancy, parenting and pediatrics and are delivered via digital programs sold to employers and health plans. The company says its services aim to reduce costs and improve clinical outcomes for parents and children. Maven plans to use the new funding to expand into new populations and to invest in additional product innovation to enhance member experience. Founded in 2014 by CEO Kate Ryder, the company is based in New York. Clients named in the article include Microsoft, Boston Scientific, Booz Allen Hamilton and L’Oreal. Maven Clinic is a New York–based digital health company offering telehealth visits and a family benefits platform focused on pregnancy, fertility, maternity and return-to-work programs. Founded in 2014 by CEO Katherine Ryder, it connects members with OB/GYNs, mental health practitioners, pediatricians and other specialists. The company has expanded its network to 1,700 providers across more than 20 specialties and recently launched Maven Wallet to track expenses for fertility, egg freezing, adoption and surrogacy. Over the last year Maven tripled its client base and struck partnerships with more than 100 companies as employers seek family benefits to retain working parents. Maven reports that 90% of its members return to work compared with a national average of 57% and says its services can reduce ER visits and lower maternity spending. The company plans to use the new funds to build out existing platforms and expand into adjacent areas of care, including pediatrics. Maven Clinic operates a digital health platform that provides fertility, adoption, postpartum depression support, mental health care, doctor referrals, and video appointments with health care professionals. The company announced a nationwide breast milk delivery service intended to complement its existing platform and serve working mothers who travel or need shipping solutions. Maven markets its services primarily as an employer-offered benefit but also makes them available to individual users through its smartphone app. Management positions the new delivery service as a way for companies to retain talent and keep mothers in the workforce. Maven was founded by CEO Kate Ryder in 2014, is based in New York City, and has 50 employees. The company has raised $42 million to date.